Perdagangan Amgen AMGN

Jual
 Beli

Amgen diagram langsung

5m 15m 30m 1h 4h 1d 1w

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Amgen news

Frances Wang 2024 Nov 26, 16:00

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

Stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Australian dollar shrugs at RBA decision to keep interest rates unchanged
Georgy Istigechev 2024 Aug 03, 21:00

Week ahead: RBA meeting, Uber earnings, and PMIs

CFD Trading Forex
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Bank of England BoE
Neil Wilson 2023 Oct 27, 10:00

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Forex Indices

Berita Terkini

Tampilkan lebih banyak
Sophia Claire 2025 Sep 30, 01:20

Potential Government Shutdown Threatens Key US Economic Data Delays

Noah Lee 2025 Sep 29, 14:20

Trump's 100% Tariff on Foreign Films: Hollywood's Future at Stake?

Liam James 2025 Sep 29, 06:20

Buffett Indicator Hits Record High: Market Valuation Concerns

Ava Grace 2025 Sep 29, 04:20

US Allies in Asia Balk at Trump's Investment Demands: South Korea and Japan Reassess Pledges

Liam James 2025 Sep 29, 03:20

US Treasury Yields Navigate Fed Uncertainty, Government Shutdown Risk

Emma Rose 2025 Sep 29, 02:20

Netanyahu-Trump Meeting: A New Gaza Peace Plan on the Table

Ava Grace 2025 Sep 29, 01:20

Fed Chair Succession: Waller vs. Hassett - Economists' Wishes vs. Political Reality

Liam James 2025 Sep 28, 06:20

Trump Mocks Powell with AI Image Amidst Rate Cut Debate

Info

Spread

1.98

Spread (%)

0.6669 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Senin

13:31 - 19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Kamis

13:31-19:59

Jumat

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

160372621312

Saham yang Beredar

538361851

Tanggal Penghasilan (Berikutnya)

1999-11-22

Hasil Div

2025-09-12

Tanggal Non-Dividen

2025-08-22

Proyeksi tingkat dividen tahunan

9.52

Proyeksi hasil dividen tahunan

0.032

EPS

12.22

Pelajari lebih lanjut tentang instrumen ini

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Instrumen Terkait

Aset
Jual
Beli
Ubah (%)

Lakukan Trading

Lakukan Trading

Lakukan Trading

Lakukan Trading
view_all_instruments

latest_education_articles

Tampilkan lebih banyak
Trustpilot